When the endocannabinoid system is blocked, the body loses some of its ability to regulate appetite, mood, pain, memory, and immune function. Depending on which receptor is blocked, effects can include reduced food intake and weight loss, but also anxiety, depressed mood, nausea, memory problems, and altered immune responses. The endocannabinoid system acts as a modulator rather than an on/off switch, so blockade often produces a mix of therapeutic and unwanted effects.
How the Endocannabinoid System Can Be Blocked
The endocannabinoid system includes two main receptors: CB1, found mostly in the brain and nervous system, and CB2, found mostly on immune cells. Researchers can block this system in several ways:
what are endocannabinoids and what do they do
- CB1 antagonists or inverse agonists: Drugs like rimonabant bind to CB1 receptors and prevent endocannabinoids such as anandamide and 2-AG from activating them.
- CB2 antagonists: Compounds that block CB2 receptors, mainly used in research on immune and inflammatory conditions.
- Genetic knockout models: Animals bred without CB1 or CB2 receptors help scientists study what happens when the system is absent.
Enzyme inhibitors such as FAAH inhibitors do not block the endocannabinoid system. They increase endocannabinoid levels by slowing their breakdown.
Role of the Endocannabinoid System in Pain Regulation
What Happens When CB1 Receptors Are Blocked
CB1 blockade has the most visible effects because CB1 receptors are widespread in the brain. Research and clinical trials show a range of outcomes:
what happens when endocannabinoid system is blocked
- Reduced appetite and food intake: CB1 blockade can lower hunger and lead to weight loss.
- Metabolic changes: Short-term studies found improvements in some lipid and glucose markers.
- Psychiatric effects: Anxiety, irritability, depressed mood, and suicidal thoughts have been reported with rimonabant. This led to its withdrawal from the market.
- Nausea and stomach upset: Blocking CB1 can disrupt gut motility and cause discomfort.
- Memory and learning: CB1 receptors in the hippocampus are involved in memory, so blockade may impair memory formation.
- Stress response: Animal studies show altered stress reactions and increased anxiety-like behavior when CB1 is blocked or missing.
What Happens When CB2 Receptors Are Blocked
CB2 receptors are mainly on immune cells, so blocking them affects inflammation and immune signaling rather than mood or appetite.
- Immune cell activity: CB2 blockade can change how immune cells migrate and release signaling molecules.
- Inflammation: The direction of change depends on the disease model. In some cases, blocking CB2 reduces inflammation; in others, it worsens it.
- Bone remodeling: Animal studies show that CB2 blockade can alter bone mass by affecting osteoclasts and osteoblasts.
- Pain perception: CB2 is involved in pain processing, so blockade may change pain sensitivity.
Effects on Daily Function and Homeostasis
The endocannabinoid system helps keep the body in balance. When it is blocked, people may notice changes in hunger, mood, sleep, stress resilience, and pain perception. Because endocannabinoids are made on demand and act locally, blockade can have different effects in different tissues. A drug that blocks CB1 in the brain may cause psychiatric side effects, while a drug that blocks CB1 only in peripheral tissues may avoid those effects.
Why Blockade Is Not a Simple On/Off Switch
The endocannabinoid system is a modulatory system. It fine-tunes neurotransmitter release rather than driving processes directly. Blocking one receptor can lead to compensatory changes in other systems, such as opioid, dopamine, or GABA signaling. Partial blockade may produce milder effects than full blockade. Also, the same receptor can have different roles in different organs. This complexity explains why blocking the endocannabinoid system can be helpful in one context and harmful in another.
Clinical and Research Implications
Rimonabant was approved in Europe for obesity but was withdrawn because of psychiatric side effects. Since then, researchers have developed peripherally restricted CB1 antagonists that aim to treat metabolic and liver conditions without entering the brain. CB2 antagonists remain under study for immune disorders, bone disease, and pain. Understanding what happens when the endocannabinoid system is blocked helps explain why cannabis and cannabinoid drugs have such varied effects on the body.
Key Takeaways
- Blocking the endocannabinoid system can reduce appetite and weight but may cause anxiety, depression, and memory problems.
- CB1 blockade has been linked to serious psychiatric side effects, including suicidal thoughts.
- CB2 blockade mainly affects immune function and bone remodeling in animal models.
- The endocannabinoid system is a modulator, so blockade produces complex, context-dependent results.